← Leaderboards
Enrico Mihich
Roswell Park Cancer Institute Corp
$1,152,699
Attributed
$1,152,699
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,152,699 · 3
By mechanism
R01$571,191 · 1
T32$408,434 · 1
R03$173,074 · 1
Top collaborators
No co-investigators on record.
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Walter J Storkus$19,974,413
- Richard B Bankert$9,763,302
- Pawel Kalinski$15,491,276
- Soldano Ferrone$11,688,743
- Elizabeth Repasky$12,725,917
Others in their field
Top investigators on “Immunomodulators”
- Fred M Gordin · Social And Scientific Systems, Inc.$75,931,872
- Johnnye L Lewis · University Of New Mexico$18,505,537
- Rama Rao Amara · Emory University$16,402,105
- Eric Hunter · University Of Alabama At Birmingham$16,402,105
- Robert H Squires · Children'S Hosp Pittsburgh/Upmc Hlth Sys$16,267,601
- Sumit K Chanda · Scripps Research Institute, The$14,981,889
Research focus
ImmunomodulatorsInterleukin 2Laboratory MouseDisease /Disorder ModelNonhuman Therapy EvaluationNatural Killer CellsGenetically Modified AnimalsDoxorubicinT LymphocyteNeoplasm /Cancer ImmunotherapyMetastasisNeoplasm /Cancer ChemotherapyNeoplasm /Cancer ImmunologyNeoplasm /Cancer PharmacologyNeoplasm /Cancer TransplantationNeoplasm /Cancer VaccineNeoplastic ProcessPassive ImmunizationProstate NeoplasmsProteoglycanAntineoplastic AntibioticsTumor Necrosis Factor AlphaAntineoplasticsBreast Neoplasms
Grant awards (8)
Chemoimmunoprevention of prostate and breast cancer$87,077
R03 · FY2004 · CA
Chemoimmunoprevention of prostate and breast cancer$85,997
R03 · FY2003 · CA
DRUG DEVELOPMENT AND CANCER TREATMENTS$139,317
T32 · FY2002 · CA
DRUG DEVELOPMENT AND CANCER TREATMENTS$29,796
T32 · FY2002 · CA
CANCER CHEMOTHERAPY AND IMMUNOLOGIC EFFECTS$264,535
R01 · FY2001 · CA
DRUG DEVELOPMENT AND CANCER TREATMENTS$128,844
T32 · FY2001 · CA
CANCER CHEMOTHERAPY AND IMMUNOLOGIC EFFECTS$306,656
R01 · FY2000 · CA
DRUG DEVELOPMENT AND CANCER TREATMENTS$110,477
T32 · FY2000 · CA